Q2 Earnings Forecast for Revvity Issued By Leerink Partnrs

Revvity, Inc. (NYSE:RVTY) – Research analysts at Leerink Partnrs cut their Q2 2025 earnings per share (EPS) estimates for shares of Revvity in a research report issued on Thursday, April 17th. Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings of $1.22 per share for the quarter, down from their previous forecast of $1.23. The consensus estimate for Revvity’s current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity’s FY2025 earnings at $4.90 EPS, Q1 2026 earnings at $1.17 EPS, Q2 2026 earnings at $1.41 EPS, Q4 2026 earnings at $1.60 EPS and FY2026 earnings at $5.59 EPS.

Other equities analysts have also recently issued research reports about the company. Barclays lowered their target price on Revvity from $140.00 to $110.00 and set an “overweight” rating for the company in a report on Thursday, April 10th. KeyCorp increased their price objective on Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Sanford C. Bernstein cut Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price on the stock. in a research note on Friday, January 10th. Wells Fargo & Company decreased their price target on shares of Revvity from $130.00 to $102.00 and set an “equal weight” rating for the company in a research note on Thursday. Finally, Raymond James reissued an “outperform” rating and issued a $145.00 price objective (up previously from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Four investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $131.42.

Revvity Trading Down 2.1 %

Shares of NYSE:RVTY opened at $91.82 on Friday. The firm has a market cap of $11.03 billion, a price-to-earnings ratio of 41.55, a PEG ratio of 3.82 and a beta of 1.07. Revvity has a 12 month low of $89.61 and a 12 month high of $129.50. The company’s fifty day simple moving average is $106.77 and its 200 day simple moving average is $114.07. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41.

Revvity (NYSE:RVTY) last announced its earnings results on Friday, January 31st. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter in the prior year, the company posted $1.25 EPS.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date is Thursday, April 17th. Revvity’s dividend payout ratio is currently 12.67%.

Insider Activity

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of the company’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the sale, the insider now owns 33,400 shares in the company, valued at $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.68% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Assetmark Inc. lifted its holdings in Revvity by 3,700.0% during the 4th quarter. Assetmark Inc. now owns 266 shares of the company’s stock valued at $30,000 after purchasing an additional 259 shares during the last quarter. Optiver Holding B.V. bought a new position in shares of Revvity in the fourth quarter valued at about $33,000. Quarry LP lifted its stake in shares of Revvity by 45.7% during the 4th quarter. Quarry LP now owns 303 shares of the company’s stock worth $34,000 after buying an additional 95 shares during the last quarter. Millstone Evans Group LLC bought a new stake in shares of Revvity during the 4th quarter worth about $38,000. Finally, Vermillion Wealth Management Inc. acquired a new position in Revvity in the 4th quarter valued at about $41,000. 86.65% of the stock is owned by institutional investors and hedge funds.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.